Seqirus | Controlled Release Society

Seqirus Receives FDA Approval of Afluria Quadrivalent® (Influenza Vaccine) for People Five Years of Age and Older in the United States

Authors:

Date:

September 14, 2017

Business Wire: September 14, 2017 – CAMBRIDGE, MA, U.S.A. – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (influenza vaccine) for use in people five years of age and older, extending the company’s broad portfolio of influenza vaccine…